ArticleOncology letters2024

Lenvatinib in combination with transarterial chemoembolization vs. sorafenib in combination with transarterial chemoembolization for unresectable hepatocellular carcinoma: A network meta‑analysis.

Yong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.